Nomura Holdings
NYMX

Nomura Holdings’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Nomura Holdings’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-19,751
Closed -$109K – 3106
2014
Q1 		$109K Buy
19,751
+8,797
+80% +$51K ﹤0.01% 2491
2013
Q4 		$66K Sell
10,954
-11,162
-50% -$76.1K ﹤0.01% 1865
2013
Q3 		$145K Buy
+22,116
New +$144K ﹤0.01% 1995

Other funds holding NYMX

AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Nomura Holdings's NYMX Position: Q2 2014 in Review

Nomura Holdings sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2014, closing a stake of 19,751 shares — an estimated $109K sold.

Nomura Holdings first reported a position in NYMX in Q3 2013 and held it in 3 quarters. The position peaked at $145K in Q3 2013. 31 funds tracked by Wall St. Rank hold NYMX as of Q2 2014.

  • Nomura Holdings reported no remaining Nymox Pharmaceutical Corp position as of Q2 2014 after selling out during the quarter.
  • Nomura Holdings sold 19,751 Nymox Pharmaceutical Corp shares in Q2 2014, an estimated $109K.
  • Nomura Holdings first reported a position in Nymox Pharmaceutical Corp in Q3 2013 and held it in 3 quarters.
  • Nomura Holdings's Nymox Pharmaceutical Corp position peaked at $145K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2014.

Based on Nomura Holdings's 13F filing for Q2 2014, filed 13 Aug 2014.